Kirk G. Nielsen

CIK: 0001523522

Transaction Breakdown

Open Market Buys (P)5 (31.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (18.8%)

Compensation grants

Other (G, F, J, C, D, …)8 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CVRX

CVRx, Inc.

Director

SGP

SpyGlass Pharma, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (16 total)

CVRX
CVRx, Inc.
Jun 1, 2026
Award(A)
Direct
8.7K shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Series D Preferred Stock
Indirect
359.3K shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Series C-2 Preferred Stock
Indirect
548.1K shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Series C-1 Preferred Stock
Indirect
548.1K shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Series B Preferred Stock
Indirect
1.7M shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Purchase(P)
Indirect
165K shares at avg. $16.00$2.6M
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Indirect
1.7M shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Indirect
548.1K shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Indirect
548.1K shares-
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Conversion(C)
Indirect
359.3K shares-
SGP
SpyGlass Pharma, Inc.
Feb 5, 2026
Award(A)
Stock Option (right to buy)
Direct
27.4K shares-
CVRX
CVRx, Inc.
Jun 3, 2025
Award(A)
Stock Option (right to buy)
Direct
19.6K shares-
CVRX
CVRx, Inc.
May 15, 2025
Purchase(P)
Indirect
11K shares at avg. $5.45$60K
CVRX
CVRx, Inc.
May 14, 2025
Purchase(P)
Indirect
61.2K shares at avg. $5.23$320K
CVRX
CVRx, Inc.
May 13, 2025
Purchase(P)
Indirect
101.4K shares at avg. $5.29$536K
CVRX
CVRx, Inc.
May 12, 2025
Purchase(P)
Indirect
25.2K shares at avg. $4.79$121K

		Type	Shares	Price		Ownership
Jun 1, 2026	CVRX CVRx, Inc.	Award(A)	8,720	-	$0	Direct
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C) Series D Preferred Stock	359,255	-	-	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C) Series C-2 Preferred Stock	548,067	-	-	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C) Series C-1 Preferred Stock	548,067	-	-	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C) Series B Preferred Stock	1,690,230	-	-	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Purchase(P)	165,000	$16.00	$2,640,000	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C)	1,690,230	-	$0	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C)	548,067	-	$0	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C)	548,067	-	$0	Indirect
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Conversion(C)	359,255	-	$0	Indirect
Feb 5, 2026	SGP SpyGlass Pharma, Inc.	Award(A) Stock Option (right to buy)	27,400	-	-	Direct
Jun 3, 2025	CVRX CVRx, Inc.	Award(A) Stock Option (right to buy)	19,554	-	-	Direct
May 15, 2025	CVRX CVRx, Inc.	Purchase(P)	10,966	$5.45	$59,795	Indirect
May 14, 2025	CVRX CVRx, Inc.	Purchase(P)	61,200	$5.23	$320,364	Indirect
May 13, 2025	CVRX CVRx, Inc.	Purchase(P)	101,413	$5.29	$536,313	Indirect
May 12, 2025	CVRX CVRx, Inc.	Purchase(P)	25,200	$4.79	$120,670	Indirect

1-16 of 16 transactions

About Nielsen Kirk G.

Nielsen Kirk G. (SEC CIK 0001523522) files insider reports with the SEC as Director of CVRx, Inc. (CVRX) and Director of SpyGlass Pharma, Inc. (SGP).

Signal8 holds 8 ownership filings by Nielsen Kirk G. (1 Form 3, 7 Form 4), filed between May 14, 2025 and Jun 3, 2026. Those filings report 16 transactions, from May 12, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nielsen Kirk G.'s filings is in MINNEAPOLIS, MN.

Recent filings by Nielsen Kirk G.

Jun 1, 2026: Grant or award of CVRX shares (Form 4, code A).
Feb 9, 2026: Conversions of SGP derivative securities (4 lines, Form 4, code C).
Feb 9, 2026: Open-market purchase of SGP shares (Form 4, code P).
Feb 9, 2026: Conversions of SGP shares (4 lines, Form 4, code C).
Feb 5, 2026: Grant or award of SGP derivative securities (Form 4, code A).

Other insiders filing for CVRx, Inc. (CVRX)

Binkowski Brent, CHIEF OPERATING OFFICER
Jain Mudit K., Director
SLATTERY JOSEPH P, Director
Hill, Mitch C., Director
Ballinger Kevin J., Director
SHADAN MARTHA, Director

How to read Form 4 transaction codes